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Members of the cadherin family have been implicated as growth regulators in multiple tumor types. Based
on recent studies from our laboratory implicating T-cadherin expression in mouse brain tumorigenesis, we
examined the role of T-cadherin in astrocytoma growth regulation. In this report, we show that T-cadherin
expression increased during primary astrocyte physiologic growth arrest in response to contact inhibition and
serum starvation in vitro, suggesting a function for T-cadherin in astrocyte growth regulation. We further
demonstrate that transient and stable reexpression of T-cadherin in deficient C6 glioma cell lines results in
growth suppression. In addition, T-cadherin-expressing C6 cell lines demonstrated increased homophilic cell
aggregation, increased cell attachment to fibronectin, and decreased cell motility. Cell cycle flow cytometry
demonstrated that T-cadherin reexpression resulted in G2 phase arrest, which was confirmed by mitotic index
analysis. This growth arrest was p53 independent, as T-cadherin could still mediate growth suppression in
p53/ mouse embryonic fibroblasts. T-cadherin-expressing C6 cell lines exhibited increased p21CIP1/WAF1, but
not p27Kip1, expression. Lastly, T-cadherin-mediated growth arrest was dependent on p21CIP1/WAF1 expression
and was eliminated in p21CIP1/WAF1-deficient fibroblasts. Collectively, these observations suggest a novel
mechanism of growth regulation for T-cadherin involving p21CIP1/WAF1 expression and G2 arrest.
Astrocytomas are the most common primary malignant can-
cer affecting the nervous system, and despite aggressive ther-
apy, the median survival of patients diagnosed with a high-
grade astrocytoma (glioma) is only 9 to 12 months (35). These
malignant glial tumors are hypothesized to develop as the
result of the stepwise accumulation of specific genetic changes
in astrocytes or astroglial precursors that promote astrocyte
transformation and malignant progression (8). Genetic events
important for astrocytoma formation and progression involve
alterations in pathways involved in mitogenic signaling, cell
cycle growth regulation, and environmental sensing. Previous
studies have demonstrated that astrocytomas harbor changes
in the epidermal and platelet-derived growth factor signaling
pathways, involving amplification, mutation, or overexpression
of these receptor tyrosine kinase molecules to result in in-
creased mitogenic signaling. Similarly, astrocytomas harbor al-
terations in the p53 and retinoblastoma (Rb) cell cycle regu-
latory pathways. Inactivating mutations in the p53, p16, and Rb
genes have been reported as well as overexpression of regula-
tors of these pathways, including cyclin-dependent kinase 4
(cdk4) and MDM2.
In contrast, alterations in molecules involved in environmen-
tal sensing have not been explored in great detail in astrocy-
tomas. Gene expression profiling experiments from our labo-
ratory on a mouse astrocytoma model have implicated the
novel cadherin molecule, T- or H-cadherin, in astrocytoma
progression. Based on these initial observations, we initiated a
detailed study of T-cadherin as a growth regulator for astro-
cytes.
Recent studies have suggested that cadherin family mem-
bers play important roles in the malignant progression of mul-
tiple human cancers. In addition to their established functions
in modulating cell-cell adhesion, cell polarity, and morphogen-
esis (1, 33, 36, 64), the classic cadherin molecules, E-cadherin
and N-cadherin, have also been implicated in the molecular
pathogenesis of breast, lung, gastric, and liver cancers (5, 6, 29,
40, 48). Loss of E-cadherin expression has been frequently
reported in a diverse number of malignant tumors and the
reintroduction of E-cadherin into highly invasive tumor cell
lines results in suppression of both invasion and growth (70).
E-cadherin and N-cadherin are cell surface glycoproteins con-
taining definitive calcium binding extracellular domains and
are anchored to the cell membrane through a transmembrane
region. E-cadherin-induced growth regulation is mediated by
the binding of catenins to the cadherin cytoplasmic tail and
results in modulation of Wnt signaling (59), -catenin/T-cell
factor signaling (26), and p27Kip1 up-regulation (11). Similar
mechanisms may underlie N-cadherin-mediated growth sup-
pression (40).
In contrast, T-cadherin (for truncated-cadherin, also desig-
nated H-cadherin or cadherin-13) lacks the conventional trans-
membrane and cytoplasmic domains and is anchored to the
membrane by a glycosylphosphatidylinositol anchor (1, 53, 69).
T-cadherin mediates calcium-dependent cell adhesion and co-
localizes with small trimeric G-proteins and SRC family ki-
nases in lipid rafts, where it may be involved in modulating
signal transduction pathways (16, 34, 50). The T-cadherin gene
maps to human chromosome 16q24, and loss of T-cadherin
expression has been reported in sporadic breast, prostate, liver,
and lung cancers (38, 68, 74). Within the nervous system,
T-cadherin is expressed in astrocytes in both the cerebral cor-
tex and medulla. T-cadherin overexpression in neuroblastoma
cells inhibits the mitogenic proliferative response to epidermal
* Corresponding author. Mailing address: Department of Neurol-
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growth factor (65) and suppresses motor axon growth (21).
The mechanism by which T-cadherin functions as a growth
regulator has not been determined.
To gain insights into the potential function of T-cadherin in
astrocytoma progression and growth regulation, we examined the
effect of T-cadherin overexpression in C6 glioma cells. In this
study, we report that T-cadherin expression increases during as-
trocyte physiological growth arrest in vitro, consistent with a role
in growth regulation. In C6 glioma cell lines stably expressing
T-cadherin, we observed reduced cell growth, increased cell at-
tachment and homophilic adhesion, and decreased cell motility.
The reduced C6 cell proliferation was associated with increased
p21CIP1/WAF1, but not p27Kip1, expression and G2 phase growth
arrest. Lastly, we demonstrate that T-cadherin growth regulation
is dependent on p21CIP1/WAF1, but not p53, expression. Col-
lectively, these results demonstrate that T-cadherin may func-
tion as a novel growth regulator in astrocytes relevant to as-
trocytoma progression by modulating p21CIP1/WAF1-mediated
growth regulation.
MATERIALS AND METHODS
Antibodies and cell culture. Anti-T-cadherin (H126), p21CIP1/WAF1 (C-19),
and p27Kip1 (C-19) polyclonal antibodies were purchased from Santa Cruz Bio-
technology (Santa Cruz, Calif.). Monoclonal anti--tubulin (T9026; clone
DM1A) antibody was obtained from Sigma (St. Louis, Mo.).
C6 rat glioma cells and fibroblast cells were passaged in Dulbecco’s Modified
Eagle’s Medium (DMEM) containing 10% fetal bovine serum and penicillin-
streptomycin. p53/ and p53/ mouse embryonic fibroblast lines were
kindly supplied by Jason Weber (Washington University, St. Louis, Mo.),
while p21CIP1/WAF1-deficient 3T3 cells were a gift from Andrew Koff (Me-
morial Sloan Kettering Cancer Center, New York, N.Y.). Primary astrocyte
cultures containing 97% glial fibrillary acidic protein-immunoreactive cells
(astrocytes) were generated from day 2 postnatal pups as previously described
(32).
T-cadherin construction, sequencing, and coupled transcription-translation
assay. Mouse T-cadherin sequence information was obtained from GenBank
(accession no. NM_019707). RNA was extracted from normal mouse brain using
TRIzol Reagent (Gibco-BRL Life Technologies), and 3 g of RNA was sub-
jected to first-strand synthesis using random polyhexamer primers and Super-
script  reverse transcriptase (Gibco-BRL Life Techologies) at 42°C. Five mi-
croliters of first-strand cDNA was PCR amplified in two separate fragments, with
the first fragment containing nucleotides 108 (initiation codon) to 1139 (5-AT
GCAGCCGAGAACTCCGCTC and 5-GTCAGTCCGACATCCAATCC-3)
and the second fragment containing nucleotides 909 to 2253 (stop codon) (5-
GACAGCGTTTGATGCAGATG-3 and 5-CTCACAGACCTGACAATAAG
C-3) for 39 cycles with a 62°C annealing step. After fragment 1 was digested with
SalI and AvaI and fragment 2 was digested with AvaI and XhoI, the two frag-
ments were ligated to XhoI-digested and calf-intestinal phosphatase-treated
pcDNA3.HisC vector. Positive clones were confirmed by direct sequencing using
the ABI PRISM dGTP BigDye Terminator ready reaction cycle sequencing kit
(version 3.0; Applied Biosystems, Foster City, Calif.). The protein product of
T-cadherin plasmid (105 kDa) was identified by coupled in vitro transcription/
translation using the anti-T-cadherin (H-126) polyclonal antibody.
Colony formation assay, direct counting, and growth in soft agar. Colony
formation (clonogenic) assays on C6 rat glioma cells and fibroblasts were per-
formed by transfecting cells with equimolar amounts of pcDNA3.T-cadherin and
pcDNA3 vector using Lipofectamine (Gibco-BRL Life Sciences). Five 100-mm-
diameter plates for each transfection were grown for 14 to 21 days in the
presence of G418 at 750 g/ml. For the colony formation assays on p53/ and
p53/ mouse embryonic fibroblasts or p21CIP1/WAF1-deficient 3T3 fibroblasts,
cotransfections with equimolar amounts of pcDNA3.T-cadherin or pcDNA3
vector along with 10-fold less pBABE.puro plasmid were performed. At 48 h
after transfection, cells were split into five 100-mm-diameter plates (105 cells for
each dish) and grown for 14 to 21 days in the presence of puromycin (1 g/ml).
The number of colonies greater than 2 mm in diameter was counted after crystal
violet staining and the mean and standard deviation (SD) were determined for
each transfection. Each of the clonogenic assay experiments was performed at
least three times with identical results.
Direct cell counting was conducted in 60-mm-diameter dishes. A total of 104
cells from each C6 clone were seeded in each of three 60-mm-diameter dishes
and counted on days 3, 5, and 7. Cells in three dishes were counted for each C6
clone at each time point. The means and SDs were determined for each time
point.
Soft agar growth assays were performed in quadruplicate on T-cadherin and
vector transfected C6 clones. Briefly, 1,000 C6 cells were equally divided into
four 24-well plate wells with medium containing 0.3% Noble agar and grown for
14 to 21 days. The number of colonies was determined by direct counting on an
inverted microscope and the mean and SD determined for each clone.
Western blotting. Western blotting was performed as previously described
using ECL chemiluminescence detection (Amersham, Arlington Heights, Ill.)
(28). The anti-T-cadherin antibody was used at a 1:1,000 dilution at 4°C over-
night. The other antibodies were used at a 1:1,000 dilution at room temperature
for 1 h.
Flow cytometry. DNA content was determined by fluorescence-activated cell
analysis of propidium iodide-stained cells on a FACS Calibur flow cytometer
(Becton Dickinson). Each analysis was performed in triplicate with identical
results. T-cadherin or vector-transfected C6 cells (105) were serum starved for
48 h. The cells were stimulated with DMEM containing 10% serum for 12, 24,
and 48 h; harvested; washed with phosphate-buffered saline (PBS); and fixed with
70% ethanol. Immediately prior to the analysis, cells were incubated with fresh
propidium iodide containing RNase A for 30 min at 37°C. A total of 104 cells
were analyzed from each sample. The debris and doublets were removed, and
singlets were analyzed using ModFitLT V2.0 software.
Mitotic index assay. A total of 104 T-cadherin-expressing C6 and vector-
transfected C6 clones were serum starved for 48 h and then stimulated with 10%
serum for 0, 4, 8, 12, and 24 h. The cells were trypsinized, washed with ice-cold
PBS, and resuspended in 6 ml of a 2% solution containing 3:1 (vol/vol) acetate
acid-ethanol at 4°C overnight. Next, the cells were resuspended in 0.5 ml of a
solution containing 3:1 (vol/vol) acetate-ethanol and 100 l of each suspension
were spread onto three slides. The slides were air dried for 30 min and stained
with Giemsa (LabChem Inc., Pittsburgh, Pa.) for 30 min. The cells were analyzed
at a magnification of 	400 to determine the mitotic status of the cells. Nuclei
with broken envelopes, chromatin condensation, or typical mitotic figures were
counted as mitotic. 200 to 300 cells were counted for T-cadherin-expressing and
vector-transfected clones. The percentage of mitotic cells was calculated at each
time point for T-cadherin-expressing and vector-transfected C6 clones. The
means and SDs were determined for each time point.
Cell spreading. Sterile glass coverslips were coated with laminin (10 mg/ml;
Sigma) at 4°C overnight in 24-well plates and washed three times with complete
medium. A total of 105 cells in 1 ml of complete medium was added to each well,
and the plates were incubated at 37°C for 90 min. The wells were washed with
warm 1% bovine serum albumin (BSA), fixed with 3.7% formaldehyde, and
permeabilized with 0.1% Triton X-100 for 10 min. After incubation with 1% BSA
for 30 min, the actin cytoskeleton was visualized with BODIPY-conjugated
phalloidin (0.2 U in 50 l; Molecular Probes, Eugene, Oreg.). Coverslips were
then washed in PBS and mounted in one drop of Fluoromount G (EM sciences)
and examined on a Zeiss Axiophot microscope and photographed.
Cell adhesion. C6 cell adhesion was performed by precoating a 96-well plate
with fibronectin (10 g/ml; Sigma) in sterile PBS at 4°C overnight. The wells were
washed twice with PBS and incubated with 2% heat-inactivated BSA for 2 h at
37°C. The cells were digested with 0.05% trypsin containing 0.5 mM CaCl2 and
resuspended at 106 cells/ml in serum-free DMEM and incubated for 2 h at 37°C.
Cells (100 l) were added to each well and allowed to adhere for 1 or 4 h. At the
end of the incubation period, cells were washed three times with PBS and stained
with 0.5% crystal violet for 30 min at room temperature. The wells were washed
three times, and 50 l of 1% sodium dodecyl sulfate was added to each well
overnight at room temperature. The number of adherent cells was quantitated by
absorbance at 540 nm. Each experiment was repeated at least three times with
identical results.
Cell aggregation assay. Cells were washed with PBS (without Ca2 and Mg2)
twice and digested with 0.05% trypsin containing 0.5 mM Ca2. Ca2 was used
to protect T-cadherin from trypsin digestion. The cells were washed with HCMF
(10 mM HEPES [pH 7.4], 0.137 M NaCl, 5.4 mM KCl, 0.34 mM
Na2HPO4  12H2O, 0.1% glucose) to remove the Ca2 and were then suspended
in 1 ml of HCMF. The cells were resuspended at 105 per 0.5 ml with HCMF, and
0.5 ml of the cell suspension was seeded in each of quadruplicate wells of 24-well
plates precoated with 1% BSA. Ca2 was added to 1 mM final concentration for
each well, while the plates were kept on ice. The plates were placed in a 37°C
shaker and rotated at 80 rpm for 1 h, which was followed by fixation with 0.5 ml
of 8% paraformaldehyde on ice for 15 min. The wells were then gently stirred.
The number of aggregates and single cells were counted with a hemacytometer,
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and the aggregation index (Nt/N0) was calculated (Nt 
 total particle number,
including aggregates and single cells; N0 
 total cell number in cell suspension).
The assay was repeated three times, and the means and SDs were determined.
Motility assay. Cells were suspended at 5 	 105 cells/ml in serum-free me-
dium. Two hundred microliters of the cell suspension (105 cells) was added in
each of triplicate Transwells with an 8.0-m-pore size (Fisher Scientific, St.
Louis, Mo.). Six hundred microliters of DMEM containing 10% serum were
added into each well of 24-well plate. Transwells were placed over the wells of
24-well plate. The plates were incubated at 37°C for 4 h. The membranes were
fixed, stained, and removed. The number of cells on the lower surface of mem-
branes was counted and the means and SDs determined. The assay was repeated
three times with identical results.
Statistical methods. Data are presented as the means SD and were analyzed
with analysis of variance followed by the t test, with significance (P) set at 0.01.
RESULTS
T-cadherin overexpression results in C6 cell growth sup-
pression in vitro. To explore the role of T-cadherin in astrocyte
growth regulation, we first examined the expression of T-cad-
herin under different physiological growth arrest conditions.
Primary neocortical astrocyte cultures have previously been
shown to undergo growth arrest in response to confluence and
serum starvation (27, 31). In these experiments, we observed
increased expression of the mature form of T-cadherin (105
kDa) 48 to 96 h after the cells became confluent or within 24
to 48 h of serum starvation at 75% confluence (Fig. 1). This
pattern of expression is consistent with T-cadherin expression
increasing during physiological growth arrest in astrocytes and
suggests that T-cadherin may be involved in the regulation of
growth in astrocytes.
Since normal cultured astrocytes express T-cadherin, we
chose to determine the effect of T-cadherin expression on cell
growth in C6 rat glioma cells. C6 cells express minimal levels of
T-cadherin under all growth conditions compared to normal
cultured human fetal or mouse neocortical astrocytes (data not
shown). In these experiments, equimolar amounts of
pcDNA3.T-cadherin and pcDNA3 were transfected into C6
cells and the colonies greater than or equal to 2 mm were
determined after selection in G418 (750 g/ml) for 14 days.
Western blotting demonstrated T-cadherin expression in the
pooled cells from the pcDNA3.T-cadherin transfected dishes
compared with the pooled cells from the pcDNA3 vector-
transfected dishes (Fig. 2A). A 70% decrease in colony number
was observed in the pcDNA3.T-cadherin-transfected dishes
(Fig. 2B and C), supporting a role for T-cadherin in astroglial
growth regulation.
FIG. 1. T-cadherin expression in primary mouse astrocytes under
different physiological growth arrest conditions. Western blotting dem-
onstrates that the mature form (105 kDa) of T-cadherin expression
gradually increases in primary mouse astrocytes after the cells reached
confluency (48 and 96 h after confluence). Similarly, T-cadherin ex-
pression gradually increased as a function of time after the cells were
serum starved for 24, 48, and 72 h at 75% confluency. The arrow
denotes the mature form of T-cadherin expression (105 kDa).
FIG. 2. Transfection of T-cadherin into C6 glioma cells results in
growth suppression. (A) Western blot demonstrates overexpression of
the mature (105-kDa) and uncleaved precursor (130-kDa) forms of
T-cadherin in C6 cells transfected with pcDNA3.T-cadherin compared
to those transfected with pcDNA3 vector. (B) Equimolar amounts of
pcDNA3.T-cadherin and pcDNA3 were transfected into C6 cells. Rep-
resentative plates are shown after 14 days of selection and quantitated
in panel C. (C) The single asterisk denotes a statistically significant
decrease in colony number in each of the three dishes transfected with
pcDNA3. T-cadherin compared to those transfected with pcDNA3
vector (P  0.01). Error bars, SDs.
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To further study T-cadherin growth suppression, we estab-
lished constitutively expressing T-cadherin C6 clones. Three
T-cadherin-overexpressing C6 cell lines and two vector-trans-
fected C6 lines were selected. T-cadherin clones T3, T9, and
T13 express various amounts of T-cadherin compared with
vector clones V2 and V3 (Fig. 3A). The same number of
T-cadherin-expressing and vector-transfected C6 cells (104)
were seeded in 60-mm-diameter dishes and the number of cells
counted on days 3, 5 and 7 (prior to confluence). We observed
a 33 to 49% decrease in cell number in the T-cadherin-express-
ing clones compared to vector clones on day 7 (Fig. 3B).
Similar results were obtained in soft agar growth assays, where
we observed an average 36.3% decrease in colony number in
T-cadherin clones compared to vector clones (Fig. 3C). In
addition, there is a strong correlation between the level of
T-cadherin overexpression in these clones and the magnitude
of the growth suppression observed.
T-cadherin overexpression enhances C6 cell spreading and
adhesion, but suppresses cell motility. Cell spreading, adhe-
sion and motility are important properties of tumor cells,
which impact on their ability to invade normal tissue. Cadherin
molecules have been shown to modulate cell motility and ad-
hesion. In an effort to determine whether T-cadherin overex-
pression in C6 glioma cells resulted in similar effects on these
tumorigenic features, we analyzed cell spreading, attachment,
homophilic adhesion, and motility. In all three T-cadherin-
overexpressing C6 cell lines, we observed increased cell spread-
ing, as determined by phalloidin-BODIPY reorganization of
the actin cytoskeleton. More than 90% of T-cadherin-express-
ing cells exhibited more extensive actin cytoskeleton reorgani-
zation at 60 to 90 min after initial plating compared with
vector-transfected controls (Fig. 4A). To determine whether
this increase in cell spreading resulted in increased attachment
to fibronectin-coated surfaces, we examined cell attachment at
1 and 4 h after plating. T-cadherin-expressing clones T3, T9,
and T13 exhibited significant increases in cell attachment at
both time points compared to vector controls (P  0.01) (Fig.
4B).
In contrast to the classical cadherins (45, 49), T-cadherin is
not concentrated in regions of cell-cell contact (1), but it can
induce calcium-dependent homophilic aggregation in CHO
cells (69) and in HEK293 cells (54). Under standard in vitro
culture conditions, T-cadherin-transfected C6 cells did not ex-
hibit increased cell-cell interactions compared with vector-
transfected C6 cells (data not shown). However, in the pres-
ence of 1 mM Ca2, T-cadherin overexpression induced
homophilic cell-cell aggregation (Fig. 5A). The aggregation
indexes for T-cadherin clones T3, T9, and T13 were reduced by
80.6, 68.4, and 50.9% compared to those of vector clones (P 
0.01) (Fig. 5B), indicating that T-cadherin overexpression in
C6 glioma cells results in increased cell-cell adhesion.
Lastly, we wished to determine whether these effects of
T-cadherin on cell adhesion, spreading, and attachment also
resulted in alterations in cell motility using a Boyden chamber
assay (Fig. 4C). Compared to vector-transfected C6 cells, we
observed a 55 to 70% reduction in cell motility in the T-
cadherin-expressing clones (P  0.01). The magnitude of the
effect of T-cadherin overexpression on cell spreading, adhe-
sion, and motility was directly related to the level of T-cadherin
overexpression.
T-cadherin overexpression induces G2 arrest and increased
aneuploidy in C6 cells. To explore the mechanism by which
T-cadherin overexpression results in decreased cell growth, cell
cycle analysis of T-cadherin-expressing and vector-transfected
FIG. 3. C6 glioma cell lines constitutively overexpressing T-cad-
herin exhibit decreased cell proliferation. (A) Western blot demon-
strates overexpression of the mature (105-kDa) and precursor (130-
kDa) forms of T-cadherin in stably transfected C6 cell clones T3, T9,
and T13. (B) Direct cell counting demonstrates that T-cadherin-ex-
pressing C6 cell clones T3, T9, and T13 have decreased cell prolifer-
ation compared to vector-transfected clones V2 and V3 on day 7 of
culture. The means and SDs are shown for each time point. Error bars,
SDs. (C) T-cadherin-overexpressing C6 cell clones (T3, T9, and T13)
formed fewer colonies in soft agar than vector-transfected C6 cell
clones (V2 and V3). The single asterisk denotes a statistically signifi-
cant decrease in colony number of T-cadherin clones compared to
vector clones. Error bars, SDs.
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C6 clones was conducted. Compared to the vector clones V2
and V3, T-cadherin-expressing clones T3 and T9 demonstrated
a significantly increased percentage of cells in G2/M phase
(52.6 and 51.84% versus 16.17 and 13.47%) and a dramatically
decreased percentage of cells in G1 (0.66 and 0.39% versus
50.6 and 57.9%) (Fig. 6B). Meanwhile, T3 and T9 showed
aneuploidy (4N) DNA histogram patterns with more than
42% of total cell population exhibiting more than 4N DNA
content, with some containing 8N DNA content. In contrast,
vector clones V2 and V3 showed no such effect, and only less
than 1.5% of cells exhibiting aneuploidy (Fig. 6C). Consistent
with the dose effect of T-cadherin overexpression on the other
phenotypes examined, we observed a smaller increase in the
percentage of cells in G2/M with the lowest expressing T-
cadherin clone 13 (38.51%) and a decreased percentage of
cells in G1 (16.03%) (Fig. 6B). Approximately 20.8% of the
FIG. 4. T-cadherin overexpression enhances cell spreading and attachment, but decreases cell motility. (A) T-cadherin-overexpressing C6 cells
exhibit more spreading than vector-transfected cells on laminin-coated coverslips at 90 min, as assessed by actin cytoskeleton reorganization.
(B) T-cadherin-overexpressing C6 cell clones (T3, T9, and T13) exhibit enhanced attachment at 1 h (left panel) and 4 h (right panel) compared
with vector-transfected C6 clones (V2 and V3). The single asterisk denotes a statistically significant increase in absorbance at 540 nm. Error bars,
SDs. (C) T-cadherin-overexpressing C6 cell clones (T3, T9, and T13) demonstrated reduced motility in a Boyden chamber motility assay after 4 h
compared to vector-transfected C6 clones (V2 and V3). The single asterisk denotes a statistically significant decrease in motility. Error bars, SDs.
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T13 cell population exhibited aneuploidy. The proportion of
aneuploid cells positively correlates with the percentage of
cells in G2 (R
2 
 0.9723) (Fig. 6D). These observations dem-
onstrate that the growth suppression associated with T-cad-
herin expression in C6 cells likely results in increased aneu-
ploidy due to G2 arrest.
To confirm this effect, we performed additional analyses on
the T-cadherin clone T3 and the vector clone V2. After syn-
chronization by serum starvation for 48 h, T-cadherin clone T3
and vector clone V2 were stimulated with DMEM containing
10% serum for 0, 12, 24, and 48 h. Flow cytometry analysis
demonstrated that the T3 T-cadherin clone exhibited signifi-
cantly increased numbers of cells in G2/M phase at all times
examined, even with serum starvation (Fig. 7A and C), com-
pared to the V2 vector clone (Fig. 7A and B). Aneuploidy was
also observed in the T3 clone at all time points. To provide
additional support for a G2 arrest, mitotic index analysis was
performed. In these experiments, the V2 clone had a high
mitotic index at 12 (21.3%  5.2%), 24 (24.8%  5.2%), and
48 (22.7%  3.0%) h after serum stimulation compared with
the T-cadherin-expressing clone T3 at the same time points
(9.1  3.7, 5.8  1.1, and 8.1  1.2%, respectively) (Fig.
8A). By comparing this mitotic index data with the flow
cytometry data, we observed the same percentages of G2/M
phase cells entering mitosis at the different time points for
the V2 clone (18.7, 23.26, and 19.53% versus 21.3%  5.2%,
24.8% 5.2% and 22.7%  3.0%). However, only 5.8% 
1.1% to 9.1%  3.7% of the T3 cells enter mitosis despite
the fact that 45.92 to 59.35% of the cells are in G2/M at 12,
24, and 48 h (Fig. 8B). These results support the notion that
there is a G2 arrest associated with T-cadherin expression.
Similarly, propidium iodide staining demonstrated that the
nuclei of the T-cadherin-expressing C6 cells were rounder
and larger than those of the vector-transfected C6 cells (Fig.
8C), which further supports a G2 phase arrest associated
with T-cadherin overexpression.
Growth inhibition mediated by T-cadherin is dependent on
p21CIP1/WAF1 up-regulation, but is independent of p53 expres-
sion. Cadherin-mediated growth suppression has been previ-
ously associated with alterations in p27Kip1 expression. But
unlike other cadherins, such as N-cadherin (40) and E-cad-
herin (11), we found no consistent change in p27Kip1 expres-
sion associated with T-cadherin overexpression (Fig. 9A).
However, T-cadherin-expressing cells exhibited increased
p21CIP1/WAF1 expression. The increase in p21CIP1/WAF1 expres-
sion observed positively correlated with the level of T-cadherin
overexpression in the individual clones (Fig. 9A). Tubulin was
included as a loading control in these experiments. Induction
of p21CIP1/WAF1 expression was also observed following tran-
sient transfection of C6 and NIH3T3 cells with T-cadherin
(data not shown).
Since T-cadherin overexpression was associated with in-
creased p21CIP1/WAF1 expression, we next wished to determine
whether T-cadherin growth suppression required p21CIP1/WAF1
expression. In fibroblasts expressing p21CIP1/WAF1, we ob-
served suppression of cell growth upon T-cadherin overexpres-
sion (Fig. 9B). In contrast, T-cadherin-mediated growth sup-
pression was not observed in p21CIP1/WAF1 deficient
fibroblasts, suggesting that T-cadherin growth suppression re-
quires p21CIP1/WAF1 expression.
Some studies have shown that p21CIP1/WAF1 expression can
be regulated at the transcriptional level by both p53-dependent
and -independent mechanisms (23). p21CIP1/WAF1 is transcrip-
tionally regulated by wild-type p53 under a wide range of stress
stimuli (18, 25). Based on these results, we wished to evaluate
whether the T-cadherin effect on cell growth required p53
expression. Using matched p53/ and p53/ mouse embry-
onic fibroblasts (MEFs), we observed similar levels of growth
suppression in response to T-cadherin overexpression (Fig.
9C). The number of colonies observed was greater in the
p53/ MEFs than in the p53/ MEFs, which was likely due
to the increased cell proliferation and survival of p53-deficient
cells. Moreover, we did not observe a statistically significant
difference in T-cadherin growth suppression related to
p53 gene dosage (data not shown). Collectively, these re-
sults suggest that the growth suppression mediated by T-cad-
herin requires p21CIP1/WAF1 expression, but is independent of
p53.
FIG. 5. T-cadherin overexpression induces C6 cell homophilic ag-
gregation. (A) T-cadherin-overexpressing C6 cell clones exhibit exten-
sive cell-cell aggregations in the presence of 1 mM Ca2. (B) The
aggregation index was calculated for each T-cadherin-overexpressing
C6 cell clone (T3, T9, and T13) and vector-transfected clone (V2 and
V3). The single asterisk denotes a statistically significant decrease in
aggregation index in T-cadherin-overexpressing clones. Error bars,
SDs.
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Studies of astrocyte growth regulation relevant to astrocy-
toma formation and progression provide a tremendous oppor-
tunity to identify key molecules which may serve as additional
targets for future drug design in the treatment of these deadly
nervous system tumors. Molecular genetic analyses of gliomas
have revealed a number of important proteins involved in
astrocytoma tumorigenesis. In addition to genes involved in
cell cycle regulation (e.g., p53, p16, CDK4, and MDM2) and
mitogenic signaling (e.g., epidermal and platelet-derived
growth factor receptors), a select number of other pathways
have been implicated in glioma formation and progression. In
the brain, astrocytes have intricate and highly choreographed
relationships with neurons and oligodendrocytes during devel-
opment and differentiation, which is in part mediated by cell
surface molecules involved in adhesion and attachment. Cad-
herins represent one such receptor system that mediates neu-
ronal and oligodendrocyte interactions with astrocytes (67).
N-cadherin promotes chick retinal neurite outgrowth (46) as
well as oligodendrocyte migration and adhesion to astrocytes
(60). Similarly, E-cadherin expression in WC5 rat astrocyte-
like cells results in increased cell adhesion and decreased cell
motility (10). In gliomas, the relationship between cadherin
molecule expression and tumorigenesis has not been resolved.
All gliomas, regardless of grade, appear to lack E-cadherin
expression, whereas N-cadherin expression is reduced in some,
but not all, studies of high-grade recurrent gliomas (2, 3, 62).
Recently, expression of another cadherin protein, cadherin-11,
was shown to be decreased in gliomas (75).
Using a transgenic mouse model of astrocytoma (B8) in
which an oncogenic H-RAS molecule was expressed in astro-
cytes, we identified T-cadherin as a protein associated with
malignant transformation. B8 mice develop high-grade astro-
cytomas within 3 months of life and die around 4 to 6 months
(14). We first noted that T-cadherin expression was increased
in malignant astrocytoma cells from B8 mice compared with
postnatal day 2 normal cultured astrocytes or nonneoplastic B8
astrocytes (28). Several T-cadherin molecular species were
noted (50, 53–54), ranging from 95 to 130 kDa. Since the active
form of the molecule is 105 kDa, it was unclear from these
studies whether this increase in T-cadherin expression was
associated with astrocyte tumorigenesis. Using additional an-
tibodies that recognize T-cadherin, we examined T-cadherin
expression in fresh surgical tumor specimens and failed to
detect expression in many of the high-grade astrocytomas (N.
Hedrick and D. H. Gutmann, unpublished observations, 2002).
This is consistent with studies on breast and lung cancers, in
which T-cadherin expression was reduced or absent in a high
proportion of tumors (38, 39, 68, 74). In addition, we noted
that the 105-kDa molecular species was decreased in human
and rat glioma cell lines compared to normal human astro-
cytes. These results suggested that T-cadherin expression
might be regulated by culture conditions in vitro. Previous
studies have demonstrated that growth factors, confluence, and
serum deprivation all modulate T-cadherin expression in other
cell types (37). Similar to these results, we found that T-cad-
herin expression increases in primary astrocytes in vitro in
response to conditions that promote growth arrest (serum star-
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tent with a role for T-cadherin in negatively regulating astro-
cyte cell growth and raise the possibility that T-cadherin
downregulation may promote astrocytoma progression.
To explore the potential role of T-cadherin in astrocytoma
growth regulation, we initially demonstrated using a clono-
genic assay that forced overexpression of T-cadherin reduced
C6 cell colony formation in vitro. We extended these findings
by establishing several T-cadherin expressing glioma cell lines.
Similarly, T-cadherin reduced astrocytoma cell growth under
both anchorage-dependent and anchorage-independent condi-
tions. Previous studies on T-cadherin in cells other than astro-
cytes have implicated T-cadherin in homophilic adhesion, cell
proliferation, and motility. T-cadherin-expressing kidney, neu-
roblastoma, and breast cancer cell lines exhibited decreased
cell growth, increased calcium-dependent adhesion, decreased
tumor invasiveness, and reduced mitogenic signaling in re-
sponse to epidermal growth factor (65, 66). In astrocytoma
cells, we also observed that T-cadherin expression was associ-
ated with increased cell adhesion to fibronectin, increased ho-
mophilic cell aggregation, and decreased cell motility.
Surprisingly, T-cadherin expression in C6 glioma cells re-
sulted in G2 phase arrest as determined by flow cytometry and
mitotic index, and induced aneuploidy (4N) in C6 cells. In
the three independently derived T-cadherin expressing cell
lines, we observed a strong positive correlation between the
level of T-cadherin overexpression and the magnitude of the
G2 arrest. In addition, the increased aneuploidy observed in
the T-cadherin-expressing clones is likely the consequence of
G2 arrest, resulting in endoreplication. G2 arrest in response to
genotoxic agents (12) or constitutive c-myc activation (20, 22)
has also been reported to result in aneuploidy.
G2 phase arrest is typically associated with DNA damage,
such as radiation (71), UV exposure (7), and genotoxic chem-
ical treatment (15), in which p38 kinase plays an important
role. In contrast, the G2 arrest by T-cadherin overexpression
was not induced by any genotoxic agents, was not associated
FIG. 7. T-cadherin overexpression after serum starvation and serum stimulation results in a consistent increase in the percentage of cells in
G2/M phase. (A) The T3 T-cadherin-overexpressing clone and the V2 vector-transfected clone were synchronized by serum starvation for 48 h and
then stimulated with DMEM containing 10% serum for 0, 12, 24, and 48 h. The DNA content was measured at each time point. The arrows depict
the positions of 2N (G1), 4N (G2/M), and 8N. The distribution of cells in G1, S and G2/M phases is graphically represented for vector-transfected
V2 (B) and T-cadherin-expressing T3 cells (C) after serum starvation and at each time point after serum stimulation. At each time point, there
are significantly more cells in G2/M in the T-cadherin-expressing cells than vector controls.
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with increased p38 activation, and could not be abolished by
treatment with the p38 kinase inhibitor SB292190 (Z. Huang
and D. H. Gutmann, unpublished observations). Caffeine is an
inhibitor of G2 arrest induced by DNA damage (43, 52,
FIG. 8. Mitotic index analysis demonstrates a G2 arrest associated
with T-cadherin-overexpression. (A) The V2 vector clone and the T3
T-cadherin-overexpressing clone cells were serum starved and then
stimulated with DMEM containing 10% serum. Mitotic index analysis
was performed as described in the Materials and Methods section at 0,
4, 8, 12, 24, and 48 h after serum stimulation. The means and SDs
(error bars) were determined for each time point. T3 demonstrates a
lower mitotic index at every time point compared with V2. The mitotic
index data and the cell cycle analysis results are graphically repre-
sented in panel B.(B) For clone V2, the percentage of cells in G2/M
phase was comparable to the observed mitotic index at 12, 24 and 48 h
after serum stimulation. In contrast, the percentage of T3 cells in G2/M
phase was significantly higher than the mitotic index at 12, 24, and 48 h
after serum stimulation. The single asterisk denotes a statistically sig-
nificant increase in percentage of G2/M phase cells (P  0.01). Error
bars, SDs. (C) Propidium iodide staining demonstrates that T-cad-
herin-overexpressing cells have rounder and larger nuclei compared to
vector-transfected C6 cells (arrowheads denote cells undergoing mito-
sis).
FIG. 9. T-cadherin-mediated growth suppression requires
p21CIP1/WAF1 expression, but is p53 independent. (A) Western blot
demonstrates that p21CIP1/WAF1 expression is elevated in T-cadherin-
overexpressing C6 cell clones (T3, T9, and T13) compared with vector-
transfected C6 cell clones (V2 and V3). The amount of increased
p21CIP1/WAF1 positively correlates with the level of T-cadherin overex-
pression. There was no consistent effect of T-cadherin overexpression
on p27Kip1 levels. Tubulin was used as a loading control. (B) Clono-
genic assays were used to demonstrate that T-cadherin could not
suppress cell growth in p21CIP1/WAF1-deficient 3T3 cells. The single
asterisk denotes a statistically significant decrease in colony number in
the p21CIP1/WAF1-expressing 3T3 cells transfected with pcDNA3.T-
cadherin (P  0.01). Error bars, SDs.(C) Clonogenic assays were used
to demonstrate that T-cadherin could suppress fibroblast cell growth in
the absence of p53 expression. The single asterisk denotes a statisti-
cally significant decrease in colony number in the p53/ and p53
MEFs transfected with T-cadherin (P  0.01). Error bars, SDs.
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57) and induces CDC2 kinase activation (51, 58, 73). In astro-
cytoma cells, caffeine failed to abolish the G2 arrest induced by
T-cadherin overexpression (Huang and Gutmann, unpublished
observations, 2002). Finally, the T-cadherin growth reduction
was not dependent on p53 expression, suggesting that G2 arrest
induced by T-cadherin is mediated by a different mechanism
from that induced by DNA damage and does not require p53
function.
Previous studies on E-cadherin and N-cadherin have impli-
cated the cyclin-dependent kinase inhibitor, p27Kip1, in E- or
N-cadherin-mediated growth suppression. In these experi-
ments, E-cadherin-dependent growth suppression of EMT/6
mouse mammary carcinoma cells was associated with in-
creased p27Kip1 expression and reduced cyclin E-cdk2 activity
(11). Similarly, N-cadherin-mediated contact inhibition of
CHO cell growth was associated with elevations in p27Kip1
expression (40). In our studies, we observed that the level of
T-cadherin overexpression strongly correlated with the magni-
tude of the increase in p21CIP1/WAF1 and not p27Kip1 expres-
sion. In addition, T-cadherin suppressed cell growth in fibro-
blasts expressing p21CIP1/WAF1, but failed to suppress in cells
lacking p21CIP1/WAF1. Collectively, these results suggest that
the mechanism by which T-cadherin suppresses cell growth is
distinct from that described for the classic cadherin molecules
and likely involves p21CIP1/WAF1.
p21CIP1/WAF1 functions as a cell cycle negative regulator
and the introduction of p21CIP1/WAF1 into normal (30) as
well as tumor cells (18) results in G1 arrest and growth
suppression. However, p21CIP1/WAF1 may also play a regu-
latory role during G2 cell cycle transition. p21
CIP1/WAF1 ac-
cumulation, in addition to its role in negatively regulating
G1/S transition, also contributes to regulation of the G2/M
transition (47). p21CIP1/WAF1 mRNA expression in human
fibroblasts exhibits bimodal periodicity with peaks in G1 and
G2/M (41) and p21
CIP1/WAF1 protein reaccumulates in the
nucleus at the onset of mitosis (17). Inducible p21CIP1/WAF1
expression causes cell cycle arrest at both G1 and G2 (9, 24,
44) and G2 arrest when p21
CIP1/WAF1 was induced at the
beginning of the S phase (63). Similarly, calcitonin receptor-
mediated growth suppression of HEK-293 cells is accompa-
nied by induction of p21CIP1/WAF1 and G2/M arrest (19).
Conversely, antisense blockade of p21CIP1/WAF1 decreases
G2 arrest in esophageal squamous cell carcinoma in re-
sponse to radiation (55). Lastly, by modulating p21CIP1/WAF1
expression, H2O2 induces a transient multiphase cell cycle
arrest including G2 arrest in mouse fibroblasts (4).
p53-dependent accumulation of p21CIP1/WAF1, at least in part,
has been shown to mediate G1 arrest caused by DNA damage
or cellular senescence (61), but also affects G2-M phase pro-
gression if the p53-dependent accumulation of p21CIP1/WAF1
occurs in G2 phase (17). However, other mechanisms involv-
ing transcriptional and posttranscriptional events, indepen-
dent of p53, have been found to contribute to the regula-
tion of p21CIP1/WAF1 expression. Transforming growth factor-
causes a rapid transcriptional induction of p21CIP1/WAF1 in a
cell line containing two mutant alleles of p53 (13). In addition,
p21CIP1/WAF1 can be induced by activated Raf (72), activated
mitogen-activated protein kinase (42), and AKT activation
(56) in a p53-indepedent manner.
Although the precise mechanism by which T-cadherin re-
sults in p21CIP1/WAF1-mediated G2 arrest and aneuploidy has
not been elucidated to date, these results identify a novel role
for T-cadherin in growth regulation. Our results demonstrate
that T-cadherin growth suppression is associated with G2
phase arrest and requires p21CIP1/WAF1 expression. Further
studies on the relationship between T-cadherin, p21CIP1/WAF1,
and G2 phase growth arrest will likely elucidate alternative
pathways important in regulating astrocyte proliferation. In
addition, given the emerging contribution of T-cadherin to the
molecular pathogenesis of a number of diverse tumor types,
future work may result in the development of novel targets for
anticancer therapies.
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